Use your browser's back button to choose another title or click here for a New Search.

How to Get the Article

 Email CTN Library (free)

PubMed Central (free)




Bookmark and Share

Substance Abuse Treatment as HIV Prevention: More Questions than Answers.

Journal of the National Medical Association 2010;102:1183-1191.

Lawrence S. Brown, Jr., MD, MPH (Addiction Research and Treatment Corporation, GNY Node), Steven Allan Kritz, MD (Addiction Research and Treatment Corporation, GNY Node), Edmund J. Bini, MD, MPH (VA New York Harbor Healthcare System, GNY Node), Benjamin Louie (Addiction Research and Treatment Corporation, GNY Node), James A. Robinson, MEd (Nathan Kline Institute for Psychiatric Research, GNY Node), Donald Alderson, MS (New York State Psychiatric Institute, GNY Node), John Rotrosen, MD (New York University, GNY Node).

As part of protocol CTN-0012, this report examines associations between the availability of human immunodeficiency virus (HIV)-related health services in substance abuse treatment programs and characteristics of the programs and patients they serve. In a cross-sectional, descriptive design, and via a validated survey, program administrators within the National Drug Abuse Treatment Clinical Trials Network provided information on program characteristics, patient characteristics (rates of risky sexual and drug behaviors and HIV infection), and the availability of 31 different HIV-related health services. Of 319 programs, 84% submitted surveys. Service availability rates ranged from: 10% (pneumococcal vaccination) to 86% (drug testing) for the 6 HIV-related services offered to all patients, 13% (Pap smear for women) to 54% (tuberculin skin testing) for the 6 services offered to new patients, 2% (sterile injection equipment) to 64% (male condoms) for the 4 risk-reduction services, 37% (Pap smear for women) to 61% (tuberculin skin testing) for the 11 biological assessments offered to HIV-positive patients, and 33% (medical treatments) to 52% (counseling) for the 4 other services offered to HIV-positive patients. The availability of these HIV-related services was associated with clinical settings, the types of addiction treatment services, the rates of risky drug and sexual behaviors, and HIV infection rates among patients. Availability of such services was below published guidelines. While the results provide another basis for the infection-related prevention benefits of substance abuse treatment, the variability in the availability of HIV-related health care deserves further study and has health policy implications in determining how to utilize substance abuse treatment in reducing drug-related HIV transmission. (Article (Peer-Reviewed), PDF, English, 2010)

Keywords: Community health services | Health services research | HIV/AIDS | Sexual risk behavior | Sexually transmitted diseases | Journal of the National Medical Association (journal)

Document No: 528, PMID: 21287899, PMCID: PMC3097534.

Submitted by the CTN Dissemination Librarians, 12/13/2010.

Alderson, Donald search
Bini, Edmund J. search mail
Brown, Lawrence S. Jr. search mail
Louie, Benjamin search mail
Kritz, Steven Allan search mail
Robinson, James A. search mail
Rotrosen, John search mail
NIDA-CTN-0012 search www
All Nodes and CTPs were asked to participate in this study

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 12/2011 --